Skip to content
  • Home
  • M & A
  • Opinion
  • Rumors
  • M&A News
  • About Us
  • Register
    • Log In
  • Contact Us
  • Home
  • M & A
  • Opinion
  • Rumors
  • M&A News
  • About Us
  • Register
    • Log In
  • Contact Us
M&A Today

M&A Today

A website dedicated to the world of M&A – transactions, ideas, insights and other relevant M&A-related resources.

  • Home
  • M & A
  • Opinion
  • Rumors
  • M&A News
  • About Us
  • Register
    • Log In
  • Contact Us

Tag: Public Markets

Who are the Other People in OPM When Global Debt Grows Faster Than the Global Economy?
Opinion 

Who are the Other People in OPM When Global Debt Grows Faster Than the Global Economy?

July 9, 2019 by M&A Today

Other People’s Money – OPM – is a crucial component for improved performance. Using debt to acquire productive assets allows for higher returns on your invested capital. The logic is sound and the returns on invested capital are, indeed, attractive. Similarly, publicly-traded…

Continue Reading
How Consolidated Can the Pharmaceuticals Industry Become?
Mergers & Acquisitions 

How Consolidated Can the Pharmaceuticals Industry Become?

May 9, 2016 by M&A Today

With Abbott’s () $25Bn bid for St. Jude Medical () made official on Thursday, and with this being only yet one more multi-billion-Dollar bid in the space this year, one is left wondering how much longer will this sector be able to…

Continue Reading
Western Digital’s shares decline faster upon boosting its SSD position with SanDisk’s acquisition. Where’s the logic?
Mergers & Acquisitions Opinion 

Western Digital’s shares decline faster upon boosting its SSD position with SanDisk’s acquisition. Where’s the logic?

February 12, 2016 by M&A Today

On October 21, 2015, Western DigitalĀ () announced its $19Bn acquisition of SanDisk (). Although not having any particular interest in the sector or the stocks, I’ve been following WDC’s stock from time to time out of curiosity. Given today’s ever-growing interest for…

Continue Reading
Endo Closes on Par Pharma – Stock goes down 10%
Mergers & Acquisitions 

Endo Closes on Par Pharma – Stock goes down 10%

September 28, 2015 by M&A Today

As discussed here previously, the FTC approved Endo’s acquisition of Par Pharmaceuticals last Friday, making the $8Bn deal official. The acquisition is aligned with Endo’s strategy and makes a lot of sense in terms of amplifying the company’s product portfolio, presence in…

Continue Reading

What we write about

Acquisition Alcohol Beer Consolidation Consumer Controversial Crisis cross-border crowdfunding Cryptocurrency Deal Fatigue debt Drug Emerging Markets Expansion global economy Globalization Insights Integration International Markets Investment IPO Latin America Leveraged Buy-Out Merger Monopoly PE Exit Pet Pharma Post Merger Public Markets Publishing Retail Sharing Economy Tech Tech Disruption Technology Telecom Thoughts Trend Turnaround Unicorns

Search on this site

Finance News

Latest on Twitter

@ ·
06.03.23

Reply on Twitter Retweet on Twitter Like on Twitter Twitter
Load More...
email
All rights reserved - M&A Today - © 2015-2023 - Privacy Policy